RGEN
Repligen Corp
Price:  
122.59 
USD
Volume:  
758,128.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-78.0%
Upside

As of 2026-04-14, the Relative Valuation of Repligen Corp (RGEN) is 27.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 122.59 USD, the upside of Repligen Corp based on Relative Valuation is -78.0%.

The range of the Relative Valuation is 21.30 - 33.41 USD.

Range Selected
Trailing P/E multiples 24.5x - 29.7x 27.1x
Forward P/E multiples 22.6x - 26.8x 24.5x
Fair Price 21.30 - 33.41 27.02
Upside -82.6% - -72.8% -78.0%
122.59 USD
Stock Price
27.02 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2026-04-10 138.37
2026-04-09 138.00
2026-04-08 137.99
2026-04-07 132.82
2026-04-06 134.74
2026-04-02 135.69
2026-04-01 136.31
2026-03-31 135.74
2026-03-30 128.45
2026-03-27 126.87
2026-03-26 131.82
2026-03-25 131.71
2026-03-24 133.99
2026-03-23 134.04
2026-03-20 131.20
2026-03-19 135.50
2026-03-18 135.47
2026-03-17 137.41
2026-03-16 132.62
2026-03-13 131.57
2026-03-12 131.06
2026-03-11 137.36
2026-03-10 140.31
2026-03-09 147.34
2026-03-06 138.24
2026-03-05 144.05
2026-03-04 144.98
2026-03-03 141.78
2026-03-02 143.98
2026-02-27 148.31
2026-02-26 153.98
2026-02-25 152.24
2026-02-24 155.15
2026-02-23 155.99
2026-02-20 156.31
2026-02-19 158.09
2026-02-18 159.11
2026-02-17 156.00
2026-02-13 157.19
2026-02-12 152.80
2026-02-11 160.60
2026-02-10 164.82
2026-02-09 165.42
2026-02-06 163.80
2026-02-05 160.90
2026-02-04 168.33
2026-02-03 173.08
2026-02-02 174.10
2026-01-30 172.09
2026-01-29 180.15